Back to blog
    Testing and Purity

    HPLC vs Mass Spectrometry: A Practical Guide to Peptide Purity Verification

    9 April 202613 min read

    HPLC and mass spectrometry are the two primary analytical methods for verifying peptide identity and purity. Understanding their strengths, limitations, and how to interpret their results is essential for any peptide research procurement decision.

    When evaluating research peptide quality, two analytical techniques dominate: High-Performance Liquid Chromatography (HPLC) and Mass Spectrometry (MS). These methods answer fundamentally different questions about a peptide sample, and understanding what each one reveals is critical for making informed procurement decisions.

    What HPLC Measures

    HPLC separates components of a mixture based on their differential interaction with a stationary phase (typically C18-bonded silica) and a mobile phase (acetonitrile/water gradient with trifluoroacetic acid). The output is a chromatogram showing peaks corresponding to different species in the sample [1].

    The purity percentage reported on a Certificate of Analysis (COA) is derived from HPLC data. It represents the area under the main peptide peak as a proportion of total peak area. A purity of 98.5% means the target peptide constitutes 98.5% of all UV-absorbing species detected at the chosen wavelength (typically 214nm or 220nm).

    What HPLC Reveals

    • Overall sample purity as a percentage
    • Presence of closely related impurities (deletion sequences, truncations, oxidised forms)
    • Relative quantity of each impurity
    • Batch-to-batch consistency when comparing chromatographic profiles

    What HPLC Does Not Reveal

    • Whether the main peak is actually the target peptide (identity confirmation requires MS)
    • Molecular weight or amino acid sequence
    • Whether counter-ions (TFA, acetate) are contributing to net peptide content
    • Non-UV-absorbing contaminants (salts, water, endotoxins)

    What Mass Spectrometry Measures

    Mass spectrometry determines the molecular weight of compounds in a sample. For peptides, electrospray ionisation (ESI-MS) or matrix-assisted laser desorption/ionisation time-of-flight (MALDI-TOF) are the standard techniques [2].

    The output is a mass spectrum showing the mass-to-charge ratio (m/z) of detected ions. For a peptide with a known sequence, the expected molecular weight can be calculated precisely. If the observed mass matches the theoretical mass within instrument tolerance (typically less than 0.1 Da for ESI-MS), identity is confirmed.

    What MS Reveals

    • Whether the sample contains the correct peptide (identity confirmation)
    • Molecular weight of the target peptide and any impurities
    • Post-translational modifications or chemical modifications (oxidation, deamidation)
    • Presence of synthesis by-products with known mass signatures

    What MS Does Not Reveal

    • Absolute purity percentage (MS is not inherently quantitative without calibration standards)
    • 3D structure or folding state
    • Biological activity

    Why Both Methods Are Required

    A COA reporting "99% purity by HPLC" without accompanying MS data is incomplete. The 99% figure indicates the sample is largely one compound, but it does not confirm that compound is the target peptide. Conversely, a positive MS identification without HPLC purity data confirms the target peptide is present but not how much of the sample it constitutes.

    Best practice for research peptide procurement requires both:

    1. HPLC chromatogram showing purity not less than 99% with a single dominant peak
    2. ESI-MS or MALDI-TOF spectrum confirming the molecular weight matches the target sequence

    Reading a COA: Red Flags

    When reviewing Certificates of Analysis from peptide suppliers, watch for these issues:

    • No chromatogram image: A purity number without the actual HPLC trace is unverifiable
    • Unspecified HPLC conditions: Column type, gradient, flow rate, and detection wavelength should be stated
    • MS data showing only molecular ion: A complete spectrum should show the charge envelope, not a single peak
    • "Purity by HPLC: >95%": Vague ranges suggest the supplier has not performed lot-specific testing
    • No lot/batch number: COAs should reference a specific batch. Generic COAs are meaningless
    • Testing date significantly older than manufacture date: Peptide stability varies. COA data should reflect the actual batch being shipped

    Independent Third-Party Verification

    For critical research applications, independent verification through accredited laboratories provides an additional layer of confidence. Accredited ISO 17025 laboratories offer peptide identity and purity testing services specifically for research-grade compounds.

    Independent testing is particularly important when:

    • Working with a new supplier for the first time
    • Peptide purity is critical to experimental validity (receptor binding assays, cell-based studies)
    • Results from a supplier-provided COA seem inconsistent with observed experimental outcomes

    Emerging Analytical Methods

    Beyond HPLC and MS, several analytical techniques are gaining adoption in peptide quality assessment:

    • Circular dichroism (CD): Assesses secondary structure and confirms proper folding
    • Nuclear magnetic resonance (NMR): Provides detailed structural information at atomic resolution
    • Capillary electrophoresis (CE): Alternative separation technique with orthogonal selectivity to HPLC
    • Limulus amebocyte lysate (LAL) assay: Specifically detects bacterial endotoxin contamination

    References

    1. [1] Snyder LR, et al. Introduction to Modern Liquid Chromatography. 3rd ed. Wiley; 2010.
    2. [2] Dass C. Fundamentals of Contemporary Mass Spectrometry. Wiley-Interscience; 2007.

    Browse the Peptx catalogue

    Independently tested compounds, typically 99%+ purity (HPLC), factory-direct pricing. UK stock dispatches within 24 hours.

    Sold strictly for laboratory research. Not for human consumption.